Table 1 Tumor volumes of increased FET-uptake and of Gd-enhancement in MRI at baseline and at time of relapse
Pat. No | Tumor volumes at baseline | Tumor volumes at relapse | ||||||
|---|---|---|---|---|---|---|---|---|
|  | FET-1 (ml) | MRI-1 (ml) | Intersect FET-1 ∩ MRI-1 (ml) | Intersect FET-1 ∩ MRI-1 (% of FET-1) | FET-2 (ml) | MRI-2 (ml) | Intersect FET-2 ∩ MRI-2 (ml) | Intersect FET-2 ∩ MRI-2 (% of FET-2) |
1 | 10.4 | 0.8 | 0.4 | 3.8 | 3.7 | 3.7 | 0.0 | 0 |
2 | 6.9 | 0.6 | 0.2 | 2.9 | 10.9 | 8.9 | 0.7 | 8.7 |
3 | 6.8 | 3.7 | 2.2 | 32.4 | 11.3 | 8.1 | 5.0 | 44.2 |
4 | 1.1 | 6.8 | 1.3 | 9.9 | 12.2 | 9.3 | 7.6 | 62.3 |
5 | 13.4 | 6.0 | 3.5 | 26.1 | 13.9 | 12.0 | 1.1 | 7.9 |
6 | 15.0 | 1.3 | 0.5 | 3.3 | 35.1 | 16.2 | 23.5 | 67.0 |
7 | 6.7 | 6.4 | 0.0 | 0.0 | 6.2 | 19.4 | 0.8 | 12.9 |
8 | 25.2 | 1.3 | 1.3 | 5.2 | 22.1 | 26.8 | 10.0 | 45.3 |
9 | 4.7 | 6.5 | 1.5 | 31.9 | 5.6 | 27.0 | 5.6 | 100 |
10 | 6.8 | 4.9 | 1.6 | 23.5 | 56.0 | 39.6 | 0.0 | 0.0 |
11 | 62.9 | 19.4 | 12.0 | 19.1 | 46.7 | 41.8 | 23.4 | 50.1 |
12 | 59.0 | 19.5 | 11.3 | 19.2 | 66.8 | 43.5 | 5.5 | 8.2 |
13 | 9.1 | 1.1 | 1.1 | 12.1 | 12.8 | 113.0 | 1.7 | 13.3 |
Mean | 17.5 | 6.0 | 3.0 | 14.6 | 23.3 | 28.4 | 6.5 | 32.3 |
Median | 9.1 | 4.9 | 1.3 | 12.1 | 12.8 | 19.4 | 5.0 | 13.3 |
SD | 19.6 | 6.1 | 4.0 | 11.5 | 20.9 | 28.8 | 8.1 | 31.5 |
range | 1.1–62.9 | 0.6–19.5 | 0–12 | 0–32.4 | 3.7–66.8 | 3.7–113 | 0–23.5 | 0-100.0 |